Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | FCN-437 |
| Trade Name | |
| Synonyms | FCN-437c|FCN437 |
| Drug Descriptions |
FCN-437 is a selective inhibitor that blocks CDK4 and CDK6 activity, which potentially inhibits proliferation of Rb1 positive tumor cells, and inhibits tumor growth (Cancer Res 2019;79(13 Suppl):Abstract nr 4425). |
| DrugClasses | CDK4/6 Inhibitor 14 |
| CAS Registry Number | NA |
| NCIT ID | C165199 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| FCN-437 | FCN-437 | 0 | 1 |
| FCN-437 + Letrozole | FCN-437 Letrozole | 0 | 0 |